Observe Medical ASA (OBSRV) Fair Value & Analysis
Healthcare · NO · Market cap 137M NOK
Fair value as of: Jun 24, 2026
Analysis
Observe Medical ASA (OBSRV) currently trades at kr 1.08, while our model-based Fair Value estimate is kr 0.9900 — implying the stock looks roughly 8.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control. Observe Medical ASA was founded in 2009 and is headquartered in Oslo, Norway.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Observe Medical ASA (OBSRV) undervalued?
What is the fair value of OBSRV?
What is the quality score of OBSRV?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.